News Archiv

EMA announces next steps for the maintenance of information on medicines in accordance with mandatory Article 57(2) requirements

The European Medicines Agency (EMA) has announced next steps for the maintanance of information on medicines in accordance with mandatory Article 57(2) requirements. On 28 June...[mehr]

EMA updates XEVPRM FAQ

The European Medicines Agency has released an updated version of the XEVPRM FAQ, document EMA/945380/2011. The new version, dated 21 June 2012 has no version number and includes...[mehr]

EMA releases further updated XEVMPD controlled vocabularies for Substances and Organisations

The European Medicines Agency (EMA) has released further updated versions of the following XEVMPD controlled vocabularies:

Organisations (WC500123647), version 4.0Substances...[mehr]

EMA launches XEVMPD e-learning course to support Article 57(2) compliance and further updates XEVMPD controlled vocabularies

The European Medicines Agency (EMA) has launched the long-awaited XEVMPD e-learning course to support compliance of Marketing Authorisation Holders (MAHs) with Art. 57 (2) of...[mehr]

EMA releases version 3 of the Controlled Vocabulary for XEVMPD Substances

The European Medicines Agency (EMA) has released a further update of their controlled vocabulary containing the list of substances published in XEVMPD.

In this new version 3, 213...[mehr]

New XEVMPD controlled vocabularies published by EMA

The European Medicines Agency (EMA) has published new versions 2.0 of some of the controlled vocabularies required to comply with the requirements on submission of...[mehr]

Exalon to speak on XEVMPD workshops organized by Lorenz Life Science Group

Dr. Michael Braun of Exalon will speak on several free XEVMPD workshops organized by one of our partners, the Lorenz Life Science Group.

Michael will give an overview...[mehr]